Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian Porter

Showing results (11-20 of 50) with videos related to

Pageof 5
Sort By:
International Journal of Rheumatic Diseases|May 26, 2017
Efficacy and safety of secukinumab in Asian patients with active ankylosing spondylitis: 52-week pooled results from two phase 3 studiesJames C-C Wei, Dominique Baeten, Joachim Sieper, et al.
Journal of Telemedicine and Telecare|June 22, 2019
Telecare management of pain and mood symptoms: Adherence, utility, and patient satisfactionMichael A Bushey, Kurt Kroenke, Julia Weiner, et al.
Rheumatology (Oxford, England)|December 28, 2018
Secukinumab shows sustained efficacy and low structural progression in ankylosing spondylitis: 4-year results from the MEASURE 1 studyJürgen Braun, Xenofon Baraliakos, Atul Deodhar, et al.
Frontiers in Immunology|December 16, 2020
Secukinumab Demonstrates Sustained Efficacy and Safety in a Taiwanese Subpopulation With Active Ankylosing Spondylitis: Four-Year Results From a Phase 3 Study, MEASURE 1Jui-Cheng Tseng, James Cheng-Chung Wei, Atul Deodhar, et al.
Practical Radiation Oncology|November 13, 2020
Diagnostic Computed Tomography Enabled Planning for Palliative Radiation Therapy: Removing the Need for a Planning Computed Tomography ScanShelley Wong, Stephanie Roderick, Alannah Kejda, et al.
Rheumatology and Therapy|August 20, 2018
Efficacy and Safety of Secukinumab 150 mg with and Without Loading Regimen in Ankylosing Spondylitis: 104-week Results from MEASURE 4 StudyAlan J Kivitz, Ulf Wagner, Eva Dokoupilova, et al.
Journal of Medical Radiation Sciences|June 10, 2026
Improving Equity of Care for Culturally and Linguistically Diverse Patients: Utilising Multilingual Software to Support Breath-Hold Breast Radiation TherapyToby Lowe, Rory Hartley, John Atyeo, et al.
Rheumatology (Oxford, England)|June 4, 2018
Modified stoke ankylosing spondylitis spinal score as an outcome measure to assess the impact of treatment on structural progression in ankylosing spondylitisDésirée van der Heijde, Jürgen Braun, Atul Deodhar, et al.
Veterinary Radiology & Ultrasound : the Official Journal of the American College of Veterinary Radiology and the International Veterinary Radiology Association|December 13, 2006
Imaging diagnosis--bacterial diskospondylitis in a goatGwendolyn J Levine, Wesley T Bissett, Robert C Cole, et al.
Rheumatology International|November 13, 2021
Nonsteroidal anti-inflammatory drug-sparing effect of secukinumab in patients with radiographic axial spondyloarthritis: 4-year results from the MEASURE 2, 3 and 4 phase III trialsMaxime Dougados, Uta Kiltz, Alan Kivitz, et al.
Pageof 5

Showing results (11-20 of 50) with videos related to

Sort By:
Pageof 5
International Journal of Rheumatic Diseases|May 26, 2017
Efficacy and safety of secukinumab in Asian patients with active ankylosing spondylitis: 52-week pooled results from two phase 3 studiesJames C-C Wei, Dominique Baeten, Joachim Sieper, et al.
Journal of Telemedicine and Telecare|June 22, 2019
Telecare management of pain and mood symptoms: Adherence, utility, and patient satisfactionMichael A Bushey, Kurt Kroenke, Julia Weiner, et al.
Rheumatology (Oxford, England)|December 28, 2018
Secukinumab shows sustained efficacy and low structural progression in ankylosing spondylitis: 4-year results from the MEASURE 1 studyJürgen Braun, Xenofon Baraliakos, Atul Deodhar, et al.
Frontiers in Immunology|December 16, 2020
Secukinumab Demonstrates Sustained Efficacy and Safety in a Taiwanese Subpopulation With Active Ankylosing Spondylitis: Four-Year Results From a Phase 3 Study, MEASURE 1Jui-Cheng Tseng, James Cheng-Chung Wei, Atul Deodhar, et al.
Practical Radiation Oncology|November 13, 2020
Diagnostic Computed Tomography Enabled Planning for Palliative Radiation Therapy: Removing the Need for a Planning Computed Tomography ScanShelley Wong, Stephanie Roderick, Alannah Kejda, et al.
Rheumatology and Therapy|August 20, 2018
Efficacy and Safety of Secukinumab 150 mg with and Without Loading Regimen in Ankylosing Spondylitis: 104-week Results from MEASURE 4 StudyAlan J Kivitz, Ulf Wagner, Eva Dokoupilova, et al.
Journal of Medical Radiation Sciences|June 10, 2026
Improving Equity of Care for Culturally and Linguistically Diverse Patients: Utilising Multilingual Software to Support Breath-Hold Breast Radiation TherapyToby Lowe, Rory Hartley, John Atyeo, et al.
Rheumatology (Oxford, England)|June 4, 2018
Modified stoke ankylosing spondylitis spinal score as an outcome measure to assess the impact of treatment on structural progression in ankylosing spondylitisDésirée van der Heijde, Jürgen Braun, Atul Deodhar, et al.
Veterinary Radiology & Ultrasound : the Official Journal of the American College of Veterinary Radiology and the International Veterinary Radiology Association|December 13, 2006
Imaging diagnosis--bacterial diskospondylitis in a goatGwendolyn J Levine, Wesley T Bissett, Robert C Cole, et al.
Rheumatology International|November 13, 2021
Nonsteroidal anti-inflammatory drug-sparing effect of secukinumab in patients with radiographic axial spondyloarthritis: 4-year results from the MEASURE 2, 3 and 4 phase III trialsMaxime Dougados, Uta Kiltz, Alan Kivitz, et al.
Pageof 5